A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We evaluated the efficacy of lenalidomide as front-line therapy for older AML patients. In this phase 2 study, patients 60 years of age or older with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fehniger, Todd A., Uy, Geoffrey L., Trinkaus, Kathryn, Nelson, Alissa D., Demland, Jeffery, Abboud, Camille N., Cashen, Amanda F., Stockerl-Goldstein, Keith E., Westervelt, Peter, DiPersio, John F., Vij, Ravi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2011
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318598/
https://ncbi.nlm.nih.gov/pubmed/21051557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-297143
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller